George Richenberg PhD thesis - Supplementary table 6.10: Summary statistics for sfFDR-identified novel genome-wide significant (FP<5x10-8), independent lead variants associated with overall (inc), overall (exc), DNMT3A-, TET2- and ASXL1-mutant CH compared with the 15 blood cell traits in BCX2

Summary statistics for novel, genome-wide significant (FP<5×10⁻⁸), independent lead variants associated with CH risk identified using the sfFDR method in individuals of European ancestry (25,657 cases and 342,869 controls). These variants were compared against association results for 15 blood cell traits measured in 562,132 European ancestry individuals from the Blood Cell Consortium (Phase 2) (PMID: 32888493).